Since 1961, Lilly has been dedicated to delivering life-changing medicines for people living with cancer. Our scientists are urgently advancing new discoveries with the goal of transforming some of the most difficult-to-treat cancers into manageable diseases. Our approach centers on creating medicines that target high confidence areas of cancer biology, show unequivocal early signs of clinical activity and will matter to patients. To accelerate the development of new cancer treatments, we are focused on expanding enrollment in clinical trials to give all patients a chance at a better outcome. When you engage with us on LinkedIn (and any other of Lilly's social media channels), you are agreeing to these Community Guidelines: Read more